Study results support continued utilization of telemedicine in urology, expert says
“[Telemedicine is] not just a form of health care delivery for emergency pandemic situations, this is something that is here to stay,” says Kara L. Watts, MD, in this video.
In this video, Kara L. Watts, MD, shares the take-home message from the recent Urology study, “Patient Satisfaction with Telephone Versus Video- Televisits: A Cross-Sectional Survey of an Urban, Multiethnic Population,” for which she served as senior author. Watts is an assistant professor of urology at Montefiore Medical Center, Bronx, New York.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
